BackArctic Bioscience AS Overview

Arctic Bioscience AS Inventory

Latest inventory for ABS.OL: $35M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$35.48M
↑ 8.96% YoYΔ $2.92M vs prior year quarter

Peer trimmed avg / median

Loading

Arctic Bioscience AS Inventory History

Loading

Arctic Bioscience AS vs. peers: Inventory Comparison

Loading

Arctic Bioscience AS Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Arctic Bioscience AS (ABS.OL) FAQ

Arctic Bioscience AS (ABS.OL) currently reports a inventory of $35M as of June 2026. That compares with $33M in the prior-year period — up 9.0% year over year. Use the charts on this page to explore Arctic Bioscience AS's inventory history and peer comparisons.

Arctic Bioscience AS's inventory increased from $33M to $35M — a 9.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arctic Bioscience AS reported $35M in inventory as of June 2026. That compares with $33M in the prior-year period — up 9.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $35M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arctic Bioscience AS, and consider following ABS.OL for alerts when major investors trade the stock.

Arctic Bioscience AS is classified in the Healthcare sector. On inventory, it currently shows $35M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABS.OL with unrelated industries.